Yingbin Fu

Yingbin Fu, Ph.D., is a Professor and holds the Sarah Campbell Blaffer Endowed Chair in the Department of Ophthalmology at Baylor College of Medicine, Houston, TX. He leads the Fu Lab, focusing on mechanisms underlying retinal degeneration and developing translational therapies for diseases like age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV).

Education: Ph.D. in Biochemistry from Michigan State University (1998), Postdoctoral Fellowship in Visual Neurophysiology at Johns Hopkins University School of Medicine (2006), and B.S. in Biochemistry from Peking University (1991).

Research Interests: Angiogenesis, cholesterol metabolism, inflammation, and neurodegeneration. The lab investigates HTRA1 and AIBP roles in AMD pathogenesis and explores gene therapy strategies to overcome anti-VEGF resistance. Recent breakthroughs include combination therapies targeting AIBP/apoA-I and anti-VEGF.

Key Awards:

• Audacious Goals Challenge Prize (National Eye Institute, 2013)
• Helen Juanita Reed Award (BrightFocus Foundation, 2018)
• 2021 NEI Audacious Goals Initiative Grant (2021–2026)

Grants & Employment: Current postdoc openings available. Research spans basic to translational projects, offering career pathways in both academia and industry.

Labs/Teams: Fu Lab emphasizes collaborative research in AMD mechanisms and regenerative therapies, with NIH-funded projects (e.g., NIH U24 grant for photoreceptor degeneration models).